Nicotinamide for Keratinocyte Carcinoma Chemoprevention: A Nationwide Survey of Mohs Surgeons

Rachel K Lim^{1

2}, Martin A Weinstock^{2

3}

Affiliations

¹ Warren Alpert Medical School of Brown University, Providence, Rhode Island.
² Department of Dermatology, Veterans Affairs Medical Center, Providence, Rhode Island.
³ School of Public Health, Brown University, Providence, Rhode Island.

Comment

Rachel K Lim et al. Dermatol Surg. 2021.

. 2021 Nov 1;47(11):1507.

doi: 10.1097/DSS.0000000000003197.

Rachel K Lim^{1

2}, Martin A Weinstock^{2

3}

¹ Warren Alpert Medical School of Brown University, Providence, Rhode Island.
² Department of Dermatology, Veterans Affairs Medical Center, Providence, Rhode Island.
³ School of Public Health, Brown University, Providence, Rhode Island.

No abstract available

Comment on

Nicotinamide for Keratinocyte Carcinoma Chemoprevention: A Nationwide Survey of Mohs Surgeons.
Desai S, Olbricht S, Ruiz ES, Hartman RI. Desai S, et al. Dermatol Surg. 2021 Apr 1;47(4):452-453. doi: 10.1097/DSS.0000000000002788. Dermatol Surg. 2021. PMID: 33625146

1. Desai S, Olbricht S, Ruiz ES, Hartman RI. Nicotinamide for keratinocyte carcinoma chemoprevention: a nationwide survey of Mohs surgeons. Dermatol Surg 2021;47:452–3.
1. Zhao Y. Nicotinamide for skin-cancer chemoprevention. N Engl J Med 2016;374:789.
1. Chen AC, Martin AJ, Choy B, Fernández-Peñas P, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 2015;373:1618–26.
1. Yelamos O, Halpern AC, Weinstock MA. Reply to “A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients”. Br J Dermatol 2017;176:551–2.
1. Weinstock MA, Thwin SS, Siegel JA, Marcolivio K, et al. Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: a randomized clinical trial. JAMA Dermatol 2018;154:167–74.